COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

Clinical trial NCT04761822 · COMPLETED

Trial details

NCT number: NCT04761822
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

SARS-CoV Infection COVID-19 Allergic Reaction Mast Cell Disorder

Start date: 2021-04-07
Primary completion: 2022-04-20
Enrollment: 746

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.